NCT02614937View on ClinicalTrials.gov

Study of Squalamine Lactate for the Treatment of Macular Edema Related to Retinal Vein Occlusion

PHASE1/PHASE2CompletedINTERVENTIONAL
Enrollment

20

Participants

Timeline

Start Date

April 30, 2013

Primary Completion Date

December 31, 2014

Study Completion Date

December 31, 2014

Conditions
Retinal Vein OcclusionMacular Edema
Interventions
DRUG

ranibizumab

0.5 mg IVT ranibizumab

DRUG

Squalamine Lactate Ophthalmic Solution, 0.2%

Squalamine Lactate Ophthalmic Solution BID

Sponsors
All Listed Sponsors
collaborator

Cumberland Valley Retina Consultants, PC

OTHER

lead

Ohr Pharmaceutical Inc.

INDUSTRY